This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid19_influenza_macrophage_XX
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid19_influenza_macrophage_XX.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org

1. Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses.

Am J Pathol 2013; 183 (3): 868-80

PMC3123873 2. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis.

Am J Pathol 2011; 179 (1): 199-210

PMC1606556 3. Kupffer cell-dependent hepatitis occurs during influenza infection.

Am J Pathol 2006; 168 (4): 1169-78; quiz 1404-5

PMC1606546 4. Systemic viral infections and collateral damage in the liver.

Am J Pathol 2006; 168 (4): 1057-9

PMC1868309 5. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung.

Am J Pathol 2003; 163 (4): 1341-55

PMC1850091 6. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.

Am J Pathol 2000; 156 (6): 1951-9

PMC1877391 7. Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study.

Am J Pathol 1990; 136 (2): 409-19

PMC2032573 8. Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice.

Am J Pathol 1976; 85 (2): 373-82

PMC6087894 9. Inhibiting Bruton's tyrosine kinase rescues mice from lethal influenza-induced acute lung injury.

Am J Physiol Lung Cell Mol Physiol 2018; 315 (1): L52-L58

PMC5495953 10. Free actin impairs macrophage bacterial defenses via scavenger receptor MARCO interaction with reversal by plasma gelsolin.

Am J Physiol Lung Cell Mol Physiol 2017; 312 (6): L1018-L1028

PMC5538876 11. Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia.

Am J Physiol Lung Cell Mol Physiol 2017; 313 (1): L138-L153

PMC4451396 12. TGF-beta-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice.

Am J Physiol Lung Cell Mol Physiol 2015; 308 (11): L1136-44

PMC4491512 13. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function.

Am J Physiol Lung Cell Mol Physiol 2015; 309 (1): L11-6

PMC4888543 14. FABP5 deficiency enhances susceptibility to H1N1 influenza A virus-induced lung inflammation.

Am J Physiol Lung Cell Mol Physiol 2013; 305 (1): L64-72

PMC5894502 15. Neutrophil-mediated T-Cell Suppression in Influenza: Novel Finding Raising Additional Questions.

Am J Respir Cell Mol Biol 2018; 58 (4): 423-425

PMC3262690 16. MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome.

Am J Respir Cell Mol Biol 2011; 45 (5): 1036-44

PMC2891499 17. MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis.

Am J Respir Cell Mol Biol 2010; 42 (6): 732-43

PMC3977719 18. Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation.

Am J Respir Crit Care Med 2014; 189 (4): 437-48

PMC3175550 19. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury.

Am J Respir Crit Care Med 2011; 184 (5): 547-60

PMC6938174 20. GM-CSF in the lung protects against lethal influenza infection.

Am J Respir Crit Care Med 2011; 184 (2): 259-68

PMC2383992 21. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus.

Am J Respir Crit Care Med 2008; 177 (10): 1103-10

PMC4325779 22. Sialic acid-binding protein Sp2CBMTD protects mice against lethal challenge with emerging influenza A (H7N9) virus.

Antimicrob Agents Chemother 2015; 59 (3): 1495-504

PMC163749 23. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus.

Antimicrob Agents Chemother 1997; 41 (3): 551-6

PMC284212 24. Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol.

Antimicrob Agents Chemother 1987; 31 (6): 920-4

PMC5903439 25. Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.

Antiviral Res 2016; 133 (ä): 208-17

26. Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine.

Antiviral Res 2016; 126 (ä): 69-80

PMC4894852 27. GM-CSF modulates pulmonary resistance to influenza A infection.

Antiviral Res 2011; 92 (2): 319-28

28. Asialoglycoprotein receptors on rat dendritic cells: possible roles for binding with Kupffer cells and ingesting virus particles.

Arch Histol Cytol 2001; 64 (2): 223-32

PMC2819217 29. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections.

Arch Pathol Lab Med 2010; 134 (2): 235-43

PMC3700531 30. Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties.

Biochem Biophys Res Commun 2013; 434 (2): 228-34

31. Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis.

Biochim Biophys Acta 1996; 1279 (2): 227-34

32. Differential mRNA expression of inflammatory cytokines in cultured human fetal membrane cells responding to influenza virus infection.

Biol Pharm Bull 2002; 25 (2): 239-43

PMC2518904 33. Toll-like receptor-mediated activation of neutrophils by influenza A virus.

Blood 2008; 112 (5): 2028-34

PMC5450074 34. Systems-based approach to examine the cytokine responses in primary mouse lung macrophages infected with low pathogenic avian Influenza virus circulating in South East Asia.

BMC Genomics 2017; 18 (1): 420

PMC3022599 35. Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection.

BMC Immunol 2010; 11 (ä): 64

PMC6389164 36. Whole transcriptome analysis reveals differential gene expression profile reflecting macrophage polarization in response to influenza A H5N1 virus infection.

BMC Med Genomics 2018; 11 (1): 20

PMC6280464 37. Antiviral response elicited against avian influenza virus infection following activation of toll-like receptor (TLR)7 signaling pathway is attributable to interleukin (IL)-1beta production.

BMC Res Notes 2018; 11 (1): 859

PMC2041048 38. Further studies of the reasons for the lack of alveolar infection during influenza in ferrets.

Br J Exp Pathol 1985; 66 (2): 217-31

PMC2041600 39. Histopathological changes in the lungs of influenza-infected mice superinfected with Staphylococcus aureus.

Br J Exp Pathol 1980; 61 (4): 415-20

PMC2072526 40. Histology and ultrastructure of metaplasia of alveolar epithelium following infection of mice and hamsters with influenza virus.

Br J Exp Pathol 1974; 55 (2): 130-7

PMC6780046 41. Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection.

Br J Pharmacol 2019; 176 (19): 3834-3844

PMC3188913 42. Role of TNF-alpha in virus-induced airway hyperresponsiveness and neuronal M(2) muscarinic receptor dysfunction.

Br J Pharmacol 2011; 164 (2b): 444-52

PMC3084614 43. Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Cancer Res 2009; 69 (10): 4309-18

44. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Cell 2008; 133 (2): 235-49

PMC6156503 45. The induction and consequences of Influenza A virus-induced cell death.

Cell Death Dis 2018; 9 (10): 1002

PMC3730437 46. Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice.

Cell Death Dis 2013; 4 (ä): e742

PMC4714358 47. Homeostatic Control of Innate Lung Inflammation by Vici Syndrome Gene Epg5 and Additional Autophagy Genes Promotes Influenza Pathogenesis.

Cell Host Microbe 2016; 19 (1): 102-13

PMC4003230 48. Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction.

Cell Mol Immunol 2010; 7 (4): 263-70

49. Low-Level Aflatoxin B1 Promotes Influenza Infection and Modulates a Switch in Macrophage Polarization from M1 to M2.

Cell Physiol Biochem 2018; 49 (3): 1110-1126

PMC6985656 50. SHP2 deficiency promotes Staphylococcus aureus pneumonia following influenza infection.

Cell Prolif 2020; 53 (1): e12721

51. Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production.

Cell Rep 2020; 30 (9): 2934-2947.e6

52. Macrophage Death following Influenza Vaccination Initiates the Inflammatory Response that Promotes Dendritic Cell Function in the Draining Lymph Node.

Cell Rep 2017; 18 (10): 2427-2440

PMC4490105 53. A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza.

Cell Rep 2015; 11 (12): 1941-52

PMC3886489 54. Immunomorphologic manifestations in mice liver infected with influenza A/H5N1, A/goose/Krasnoozerskoye/627/05 strain.

Clin Dev Immunol 2013; 2013 (ä): 342686

PMC170173 55. Impairment of monocytic function after influenza virus infection.

Clin Diagn Lab Immunol 1995; 2 (4): 426-33

PMC1554002 56. Inactivation of influenza virus by human lymphocytes.

Clin Exp Immunol 1974; 16 (4): 583-91

57. Host immunological response and factors associated with clinical outcome in patients with the novel influenza A H7N9 infection.

Clin Microbiol Infect 2014; 20 (8): O493-500

PMC5382437 58. Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment.

Clin Transl Immunology 2017; 6 (3): e135

PMC3697446 59. Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae.

Clin Vaccine Immunol 2013; 20 (7): 977-85

PMC3020331 60. Pathological and ultrastructural analysis of surgical lung biopsies in patients with swine-origin influenza type A/H1N1 and acute respiratory failure.

Clinics (Sao Paulo) 2010; 65 (12): 1229-37

PMC3368063 61. Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection.

Comp Immunol Microbiol Infect Dis 2012; 35 (4): 309-17

PMC2736785 62. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza.

Comp Med 2007; 57 (1): 82-9

PMC4057515 63. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice.

Crit Care 2013; 17 (6): R301

PMC3705720 64. Innate immune function and mortality in critically ill children with influenza: a multicenter study.

Crit Care Med 2013; 41 (1): 224-36

PMC3942671 65. Macrophages clean up: efferocytosis and microbial control.

Curr Opin Microbiol 2014; 17 (ä): 17-23

PMC4148900 66. Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages.

Cytokine 2013; 62 (1): 151-9

PMC4215537 67. Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target.

Elife 2014; 3 (ä): ä

68. An absence of reactive oxygen species improves the resolution of lung influenza infection.

Eur J Immunol 2006; 36 (6): 1364-73

69. T-705 (Favipiravir) suppresses tumor necrosis factor alpha production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug.

Acta Virol 2017; 61 (1): 48-55

70. A mouse model of swine influenza virus H9N2 infection with acute lung injury.

Acta Virol 2012; 56 (3): 227-33

71. Interleukin 12 is a primary cytokine responding to influenza virus infection in the respiratory tract of mice.

Acta Virol 2009; 53 (4): 233-40

72. Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia.

Acta Virol 2009; 53 (4): 225-31

73. The role of cytokines in the immune response to influenza A virus infection.

Acta Virol 2006; 50 (3): 151-62

74. The role of suppressive macrophages in influenza virus-induced immunosuppression.

Acta Virol 1989; 33 (3): 262-9

75. ROLE OF MACROPHAGES IN PHAGOCYTOSIS OF CYTOPLASMIC INCLUSIONS IN EXPERIMENTAL INFLUENZA OF WHITE MICE.

Acta Virol 1964; 8 (ä): 556-60

76. Morphine alters the immune response to influenza virus infection in Lewis rats.

Adv Exp Med Biol 1998; 437 (ä): 73-82

77. Morphological aspects of the local immune response to influenza in rats.

Adv Exp Med Biol 1982; 149 (ä): 225-33

78. Role of the monocyte-macrophage in influenza virus infection of lymphocytes: implications for HIV infection.

AIDS Res Hum Retroviruses 1990; 6 (8): 965-6

79. Reaktionen von Influenzaviren mit thymusabhangigen Lymphozyten.

Allerg Immunol (Leipz) 1982; 28 (3): 165-73

80. Activation of the interleukin-34 inflammatory pathway in response to influenza A virus infection.

Am J Med Sci 2015; 349 (2): 145-50

81. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis.

Am J Pathol 2013; 183 (4): 1258-1268

82. Early regulation of viral infection reduces inflammation and rescues mx-positive mice from lethal avian influenza infection.

Am J Pathol 2013; 182 (4): 1308-21

PMC6993551 83. Tissue-Resident Alveolar Macrophages Do Not Rely on Glycolysis for LPS-induced Inflammation.

Am J Respir Cell Mol Biol 2020; 62 (2): 243-255

PMC6890408 84. Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.

Am J Respir Cell Mol Biol 2019; 61 (6): 689-701

85. Neutrophil-mediated Suppression of Influenza-induced Pathology Requires CD11b/CD18 (MAC-1).

Am J Respir Cell Mol Biol 2018; 58 (4): 492-499

86. Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke.

Am J Respir Cell Mol Biol 2014; 50 (5): 963-73

87. Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation.

Am J Respir Cell Mol Biol 2013; 48 (1): 17-26

88. Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus.

Am J Respir Cell Mol Biol 2002; 26 (3): 277-82

89. The effect of T-cell depletion on enhanced basophil histamine release after in vitro incubation with live influenza A virus.

Am J Respir Cell Mol Biol 1992; 7 (4): 434-40

90. GM-CSF and influenza: will saving mice help humans?

Am J Respir Crit Care Med 2011; 184 (2): 157-8

91. Lung pathology in fatal novel human influenza A (H1N1) infection.

Am J Respir Crit Care Med 2010; 181 (1): 72-9

92. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice.

Am J Respir Crit Care Med 1998; 157 (3 Pt 1): 853-7

93. Management of the virulent influenza virus infection by oral formulation of nonhydrolized carnosine and isopeptide of carnosine attenuating proinflammatory cytokine-induced nitric oxide production.

Am J Ther 2012; 19 (1): e25-47

94. Dhori virus (Orthomyxoviridae: Thogotovirus) infection of mice produces a disease and cytokine response pattern similar to that of highly virulent influenza A (H5N1) virus infection in humans.

Am J Trop Med Hyg 2008; 78 (4): 675-80

95. Stimulated human alveolar macrophages secrete interferon.

Am Rev Respir Dis 1985; 131 (5): 714-8

96. Influenza virus infection of human alveolar and peripheral blood-derived macrophages. Production of factors that alter fibroblast proliferation.

Am Rev Respir Dis 1984; 130 (1): 98-102

97. Human alveolar macrophage support of lymphocyte responses to mitogens and antigens. Analysis and comparison with autologous peripheral-blood-derived monocytes and macrophages.

Am Rev Respir Dis 1983; 128 (3): 516-22

98. Alveolitis induced by influenza virus.

Am Rev Respir Dis 1983; 128 (4): 730-9

99. Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia.

Am Rev Respir Dis 1982; 126 (5): 778-82

100. Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages.

Am Rev Respir Dis 1977; 115 (2): 269-77

101. Alterations fonctionnelles et morphologiques de l'epithelium cilie des voies aeriennes superieures chez l'animal immunise localement par le virus grippal. I.--Comparaison de l'index de migration des macrophages et de l'inhibition du mouvement ciliaire

Ann Immunol (Paris) 1976; 127 (5): 733-59

102. Etude de la phagocytose du virus grippal par les macrophages alveolaires de cobaye. II. Effets de la phagocytose du virus grippal sur le metabolisme cellulaire.

Ann Inst Pasteur Lille 1965; 16 (ä): 11-5

103. Etude de la phogocytose du virus grippal par les macrophages alveolaires de cobaye. I. Aspects morphologiques et cinetiques en microscopie electronique et en microcinematographie en contraste de phase.

Ann Inst Pasteur Lille 1965; 16 (ä): 1-10

104. Interactions entre le virus grippal et le macrophage alveolaire de souris: etude in vitro.

Ann Microbiol (Paris) 1979; 130 A (1): 119-32

105. Effets de la depression et de la stimulation du systeme phagocytaire mononuclee sur l'evolution de la grippe experimentale de la souris.

Ann Microbiol (Paris) 1979; 130B (2): 235-44

106. Vitamin D: a new anti-infective agent?

Ann N Y Acad Sci 2014; 1317 (ä): 76-83

107. Immunology of respiratory viral infections.

Annu Rev Med 1988; 39 (ä): 147-62

108. Mitochondrial Reactive Oxygen Species Contribute to Pathological Inflammation During Influenza A Virus Infection in Mice.

Antioxid Redox Signal 2019; ä (ä): ä

109. Immune response after a single intravenous peramivir administration in children with influenza.

Antivir Ther 2018; 23 (5): 435-441

110. Baicalin inhibits autophagy induced by influenza A virus H3N2.

Antiviral Res 2015; 113 (ä): 62-70

111. Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells.

Antiviral Res 2014; 106 (ä): 95-104

112. Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells.

Antiviral Res 2013; 97 (1): 41-8

113. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.

Antiviral Res 2011; 92 (2): 346-55

114. Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice.

Antiviral Res 2010; 85 (2): 373-80

115. Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog.

Antiviral Res 1995; 26 (2): 145-59

116. Influence of inhaled cadmium on the immune response to influenza virus.

Arch Environ Health 1991; 46 (1): 50-6

117. Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation.

Eur J Immunol 2001; 31 (3): 726-33

118. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens.

Eur J Immunol 1998; 28 (2): 479-87

119. Tyk2 as a target for immune regulation in human viral/bacterial pneumonia.

Eur Respir J 2017; 50 (1): ä

PMC6902725 120. The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model.

FASEB J 2019; 33 (11): 12188-12199

121. Targeting a metabolic pathway to fight the flu.

FEBS J 2017; 284 (2): 218-221

122. Regulation of kynurenine biosynthesis during influenza virus infection.

FEBS J 2017; 284 (2): 222-236

PMC5985826 123. Immunopathology of Experimental Models of Syphilis, Influenza, and Asthma.

For Immunopathol Dis Therap 2016; 7 (3-4): 225-236

PMC6694206 124. Influenza Virus Infection Induces ZBP1 Expression and Necroptosis in Mouse Lungs.

Front Cell Infect Microbiol 2019; 9 (ä): 286

PMC5471324 125. Geldanamycin Reduces Acute Respiratory Distress Syndrome and Promotes the Survival of Mice Infected with the Highly Virulent H5N1 Influenza Virus.

Front Cell Infect Microbiol 2017; 7 (ä): 267

PMC6178135 126. STAT2 Signaling Regulates Macrophage Phenotype During Influenza and Bacterial Super-Infection.

Front Immunol 2018; 9 (ä): 2151

PMC6062652 127. Human CD49a(+) Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus.

Front Immunol 2018; 9 (ä): 1671

PMC5962662 128. Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.

Front Immunol 2018; 9 (ä): 975

PMC5502347 129. Inhibition of the NOD-Like Receptor Protein 3 Inflammasome Is Protective in Juvenile Influenza A Virus Infection.

Front Immunol 2017; 8 (ä): 782

PMC5360710 130. The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond.

Front Immunol 2017; 8 (ä): 313

PMC5328987 131. Interferon Lambda: Modulating Immunity in Infectious Diseases.

Front Immunol 2017; 8 (ä): 119

PMC5318425 132. Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.

Front Immunol 2017; 8 (ä): 178

PMC4435071 133. Mast cells and influenza a virus: association with allergic responses and beyond.

Front Immunol 2015; 6 (ä): 238

PMC6361828 134. Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome.

Front Microbiol 2019; 10 (ä): 50

PMC2759142 135. Current status of monocyte differentiation-inducing (MDI) factors derived from human fetal membrane chorion cells undergoing apoptosis after influenza virus infection.

Gene Regul Syst Bio 2007; 1 (ä): 295-302

PMC3495788 136. Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages.

Gut Microbes 2012; 3 (6): 510-22

137. Indirubin-3'-oxime as an antiviral and immunomodulatory agent in treatment of severe human influenza virus infection.

Hong Kong Med J 2018; 24 Suppl 6 (5): 45-47

138. Interferon dysregulation and virus-induced cell death in avian influenza H5N1 virus infections.

Hong Kong Med J 2012; 18 Suppl 2 (ä): 12-6

139. Prostaglandin E2: the villain in the host response to influenza virus.

Immunity 2014; 40 (4): 453-4

PMC2765464 140. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1.

Immunity 2009; 30 (4): 566-75

PMC5990420 141. Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication.

Immunobiology 2017; 222 (11): 979-988

PMC2266032 142. The impact of successive infections on the lung microenvironment.

Immunology 2007; 122 (4): 457-65

PMC1782065 143. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.

Immunology 2005; 114 (1): 112-20

PMC1385967 144. Suppressor cells induced by influenza virus inhibit interleukin-2 production in mice.

Immunology 1990; 69 (3): 454-9

PMC1385481 145. Functional studies on macrophage populations in the airways and the lung wall of SPF mice in the steady-state and during respiratory virus infection.

Immunology 1988; 65 (3): 417-25

PMC5116722 146. Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.

Infect Immun 2016; 84 (12): 3445-3457

PMC4645412 147. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.

Infect Immun 2015; 83 (12): 4617-29

PMC1932876 148. Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.

Infect Immun 2007; 75 (6): 3102-11

PMC313571 149. Pulmonary antibacterial defenses during mild and severe influenza virus infection.

Infect Immun 1990; 58 (9): 2809-14

PMC351166 150. Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages.

Infect Immun 1982; 35 (3): 1142-6

PMC551451 151. Role of macrophage activation and interferon in the resistance of alveolar macrophages from infected mice to influenza virus.

Infect Immun 1982; 36 (3): 1154-9

PMC347883 152. Staphylococcal clearance and pulmonary macrophage function during influenza infection.

Infect Immun 1982; 38 (3): 1256-62

PMC347882 153. Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection.

Infect Immun 1982; 38 (3): 1249-55

PMC351374 154. Interaction of influenza virus with mouse macrophages.

Infect Immun 1981; 31 (2): 751-7

PMC414545 155. Appearance of rosette-forming macrophages in the lungs of influenza virus-infected mice.

Infect Immun 1979; 25 (3): 986-91

PMC414666 156. Effect of influenza infection on the phagocytic and bactericidal activities of pulmonary macrophages.

Infect Immun 1979; 26 (2): 651-7

PMC422173 157. Cellular changes in lungs of mice infected with influenza virus: characterization of the cytotoxic responses.

Infect Immun 1978; 22 (2): 423-9

PMC421968 158. Morphological and cytochemical characterization of cells infiltrating mouse lungs after influenza infection.

Infect Immun 1978; 21 (1): 140-6

PMC422225 159. Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro.

Infect Immun 1978; 22 (3): 758-62

PMC420687 160. Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression.

Infect Immun 1976; 13 (3): 844-54

PMC414898 161. Respiratory tract cell-mediated immunity: comparison of primary and secondary response.

Infect Immun 1974; 9 (5): 858-62

PMC414922 162. Specific and nonspecific cell-mediated resistance to influenza virus in mice.

Infect Immun 1974; 9 (6): 991-8

PMC3825492 163. MHV68 latency modulates the host immune response to influenza A virus.

Inflammation 2013; 36 (6): 1295-303

164. The effect of Corynebacterium parvum in influenza infected mice.

Arch Immunol Ther Exp (Warsz) 1989; 37 (3-4): 421-30

165. Interferon and humoral immune response in experimental influenza: infection with A/PR8 virus adapted to the mouse.

Arch Immunol Ther Exp (Warsz) 1980; 28 (2): 323-8

166. Effect on influenza virus infection on the production of interferon by alveolar and peritoneal cells in vitro.

Arch Immunol Ther Exp (Warsz) 1980; 28 (1): 93-7

167. In vitro studies on cellular immunity in mice infected with influenza virus.

Arch Immunol Ther Exp (Warsz) 1978; 26 (1-6): 541-5

168. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.

Arch Med Res 2009; 40 (8): 655-61

169. Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection.

Arch Virol 2014; 159 (2): 267-75

170. Induction of TNF-alpha in human macrophages by avian and human influenza viruses.

Arch Virol 2010; 155 (8): 1273-9

171. Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission.

Arch Virol 2009; 154 (2): 227-33

172. Use of FITC-labeled influenza virus and flow cytometry to assess binding and internalization of virus by monocytes-macrophages and lymphocytes.

Arch Virol 1993; 130 (3-4): 441-55

173. Verapamil inhibits influenza A virus replication.

Arch Virol 1984; 81 (1-2): 163-70

174. In vivo studies of parainfluenza I (6/94) virus: mononuclear cell interactions.

Arch Virol 1975; 49 (1): 25-31

175. [Postmortem diagnosis of influenza during its epidemic and interepidemic periods].

Arkh Patol 2015; 77 (2): 22-27

176. [Pathogenic aspects of influenza during the epidemics caused by A/H1N1v virus in 2009-2010 according autopsy data].

Arkh Patol 2011; 73 (6): 21-5

177. Morfologiia grippoznoi infektsii v prodromal'nom periode (eksperimental'noe issledovanie).

Arkh Patol 1978; 40 (4): 19-24

178. Patologicheskaia anatomiia i patogenez grippa.

Arkh Patol 1977; 39 (7): 3-14

179. Pathophysiology of the alveolar macrophage system.

Aspen Emphysema Conf 1967; 10 (ä): 463-80

180. Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice.

Atherosclerosis 2010; 208 (1): 90-6

181. Pathobiology of highly pathogenic avian influenza virus H5N2 infection in juvenile ostriches from South Africa.

Avian Dis 2012; 56 (4 Suppl): 966-8

182. Effect of avian influenza virus infection on the phagocytic function of systemic phagocytes and pulmonary macrophages of turkeys.

Avian Dis 1994; 38 (1): 93-102

183. Effect of an H5N1 avian influenza virus infection on the immune system of mallard ducks.

Avian Dis 1993; 37 (3): 845-53

184. Inhibition of nitric oxide induction from avian macrophage cell lines by influenza virus.

Avian Dis 1993; 37 (3): 868-73

185. Differences in highly pathogenic avian influenza viral pathogenesis and associated early inflammatory response in chickens and ducks.

Avian Pathol 2013; 42 (4): 347-64

186. Immunohistochemical demonstration of influenza A nucleoprotein in lungs of turkeys with natural and experimental influenza respiratory disease.

Avian Pathol 1992; 21 (4): 547-57

187. [Study on the histopathology of cats inoculated with H5N1 subtype high pathogenic avian influenza virus originated from tigers].

Bing Du Xue Bao 2007; 23 (6): 477-80

188. Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice.

Biochem Biophys Res Commun 2019; 513 (2): 405-411

189. Alteraciones morfologicas en pulmon por la influenza A H1N1/v09 en autopsias, Colombia, 2009.

Biomedica 2011; 31 (3): 372-80

190. Immunomorfologicheskie izmeneniia v golovnom mozge myshei pri intratserebral'nom vvedenii neirotropnogo shtamma virusa grippa.

Biull Eksp Biol Med 1991; 112 (9): 275-8

191. O nespetsifichnosti fenomena fagotsitoza virusov grippa makrofagami myshei.

Biull Eksp Biol Med 1985; 100 (7): 55-7

192. Osobennosti vzaimodeistviia virusa grippa i makrofagov v realizatsii immunnogo otveta.

Biull Eksp Biol Med 1980; 90 (8): 192-4

193. Izuchenie toksicheskogo deistviia virusa grippa na limfoidno-makrofagal'nye reaktsii morskikh svinok

Biull Eksp Biol Med 1976; 81 (4): 497-9

194. Izmenenie fagotsitarnoi aktivnosti kletok peritoneal'nogo ekssudata myshei, immunizirovannykh virusom grippa.

Biull Eksp Biol Med 1969; 68 (12): 59-62

195. Role of the sialophorin (CD43) receptor in mediating influenza A virus-induced polymorphonuclear leukocyte dysfunction.

Blood 1995; 85 (6): 1615-9

196. Macrophage participation in influenza-induced sleep enhancement in C57BL/6J mice.

Brain Behav Immun 2004; 18 (4): 375-89

197. The participation of antiviral immune mechanisms in alveolar macrophage dysfunction during viral pneumonia.

Bull Eur Physiopathol Respir 1983; 19 (2): 173-8

198. Preventive Effects of Oxidized Dextran on Functional Activity of Pulmonary Macrophages in Mice Infected with Influenza A Virus.

Bull Exp Biol Med 2018; 165 (1): 57-60

199. Signal Immune Reactions of Macrophages Differentiated from THP-1 Monocytes to Infection with Pandemic H1N1PDM09 Virus and H5N2 and H9N2 Avian Influenza A Virus.

Bull Exp Biol Med 2018; 164 (5): 636-640

200. Study of SMAD-Dependent Signal Pathway in the Development of Early Pulmonary Fibrosis in Mice Infected with Influenza A/H1N1 Virus.

Bull Exp Biol Med 2017; 162 (5): 647-649

201. Expression of profibrotic growth factors and their receptors by mouse lung macrophages and fibroblasts under conditions of acute viral inflammation in influenza A/H5N1 virus.

Bull Exp Biol Med 2014; 156 (6): 833-7

202. Role of matrix metalloproteinases and their inhibitor in the development of early pulmonary fibrosis in mice infected with influenza A/H5N1 A/goose/Krasnoozerskoye/627/05 virus.

Bull Exp Biol Med 2013; 156 (1): 11-4

203. Structural and functional changes in pulmonary macrophages and lungs of mice infected with influenza virus A/H5N1 A/goose/Krasnoozerskoye/627/05.

Bull Exp Biol Med 2012; 153 (2): 229-32

204. Aspects cliniques de l'infection humaine par le virus de l'influenza aviaire.

Bull Mem Acad R Med Belg 2009; 164 (10): 252-6

205. Genetisch bedingte Resistenz Gegenueber Influenzavirus.

Bull Schweiz Akad Med Wiss 1977; 33 (4-6): 243-8

206. Modulation of murine macrophage responses stimulated with influenza glycoproteins.

Can J Microbiol 1992; 38 (3): 188-92

PMC6739161 207. Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.

Cell Immunol 2019; 344 (ä): 103949

208. Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase.

Cell Immunol 1990; 129 (1): 104-11

209. Ultrastructure of an influenza virus-specific cytotoxic T-cell clone and its interaction with P815 and macrophage targets.

Cell Immunol 1982; 68 (2): 276-86

210. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.

Circulation 2002; 106 (9): 1127-32

211. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.

Circulation 2001; 103 (18): 2283-8

212. Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys.

Clin Infect Dis 2015; 60 (4): 586-95

213. Fatal interstitial pneumonitis and English (London) influenza. Three case reports which illustrate the typical bacteria-free course of infection.

Clin Pediatr (Phila) 1973; 12 (12): 681-3

214. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.

Clin Sci (Lond) 2017; 131 (18): 2347-2362

215. Contribution of innate immune cells to pathogenesis of severe influenza virus infection.

Clin Sci (Lond) 2017; 131 (4): 269-283

216. Combination therapy with hepatocyte growth factor and oseltamivir confers enhanced protection against influenza viral pneumonia.

Curr Mol Med 2014; 14 (5): 690-702

217. Modulating airway defenses against microbes.

Curr Opin Pulm Med 2002; 8 (3): 154-65

218. Cytokines Induced During Influenza Virus Infection.

Curr Pharm Des 2017; 23 (18): 2616-2622

219. The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options.

Curr Top Microbiol Immunol 2015; 386 (ä): 3-22

220. Protein profiling of nasopharyngeal aspirates of hospitalized and outpatients revealed cytokines associated with severe influenza A(H1N1)pdm09 virus infections: A pilot study.

Cytokine 2016; 86 (ä): 10-14

221. Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice.

Cytokine 2010; 51 (2): 151-7

222. How TNF was recognized as a key mechanism of disease.

Cytokine Growth Factor Rev 2007; 18 (3-4): 335-43

223. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression.

Cytokine Growth Factor Rev 2001; 12 (2-3): 171-80

224. Assessment of resistance to influenza virus infection in animal models.

Dev Biol Stand 1975; 28 (ä): 307-18

225. Analiz mekhanizmov rezistentnosti k virusu grippa kletok immunoi sistemy.

Dokl Akad Nauk SSSR 1980; 251 (3): 725-8

PMC6518015 226. Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenza.

EMBO J 2019; 38 (10): ä

227. Nitrogen dioxide exposure in vivo and human alveolar macrophage inactivation of influenza virus in vitro.

Environ Res 1989; 48 (2): 179-92

228. The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology.

Environ Toxicol Pharmacol 2015; 40 (3): 924-30

229. Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis.

Eur J Clin Invest 1999; 29 (1): 83-92

230. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages.

Eur J Immunol 1997; 27 (4): 886-90

231. Selenium deficiency induced an altered immune response and increased survival following influenza A/Puerto Rico/8/34 infection.

Exp Biol Med (Maywood) 2007; 232 (3): 412-9

232. Macrophage immunity to influenza virus: in vitro and in vivo studies.

Exp Cell Biol 1979; 47 (3): 190-201

233. Pathology of influenza hepatitis in susceptible and genetically resistant mice.

Exp Cell Biol 1976; 44 (2): 95-107

234. Discrimination of resident and infiltrated alveolar macrophages by flow cytometry in influenza A virus-infected mice.

Exp Lung Res 2005; 31 (3): 323-39

PMC3645688 235. A role for protein phosphatase 2A in regulating p38 mitogen activated protein kinase activation and tumor necrosis factor-alpha expression during influenza virus infection.

Int J Mol Sci 2013; 14 (4): 7327-40

PMC6637675 236. Pathology of A(H5N8) (Clade 2.3.4.4) Virus in Experimentally Infected Chickens and Mice.

Interdiscip Perspect Infect Dis 2019; 2019 (ä): 4124865

PMC5733583 237. Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages.

J Biol Chem 2017; 292 (50): 20437-20448

238. Role of phosphatidylserine exposure and sugar chain desialylation at the surface of influenza virus-infected cells in efficient phagocytosis by macrophages.

J Biol Chem 2002; 277 (20): 18222-8

PMC5679162 239. HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription and for survival during viral infections.

J Exp Med 2017; 214 (11): 3263-3277

PMC2626661 240. Inflammasome recognition of influenza virus is essential for adaptive immune responses.

J Exp Med 2009; 206 (1): 79-87

PMC2271005 241. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.

J Exp Med 2008; 205 (2): 323-9

PMC2212304 242. The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming.

J Exp Med 1998; 187 (11): 1799-811

PMC2188600 243. Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells.

J Exp Med 1990; 172 (4): 1225-31

PMC2188048 244. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity.

J Exp Med 1986; 163 (3): 511-9

PMC2184824 245. Genetically determined, interferon-dependent resistance to influenza virus in mice.

J Exp Med 1979; 149 (3): 601-12

PMC3168279 246. Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses.

J Gen Virol 2011; 92 (Pt 6): 1428-1434

PMC4868659 247. Resistance to Acute Macrophage Killing Promotes Airway Fitness of Prevalent Community-Acquired Staphylococcus aureus Strains.

J Immunol 2016; 196 (10): 4196-203

248. Inducible Major Vault Protein Plays a Pivotal Role in Double-Stranded RNA- or Virus-Induced Proinflammatory Response.

J Immunol 2016; 196 (6): 2753-66

PMC4417391 249. Obesity Increases Mortality and Modulates the Lung Metabolome during Pandemic H1N1 Influenza Virus Infection in Mice.

J Immunol 2015; 194 (10): 4846-59

PMC4134993 250. Macrophage- and neutrophil-derived TNF-alpha instructs skin langerhans cells to prime antiviral immune responses.

J Immunol 2014; 193 (5): 2416-26

PMC4509623 251. Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.

J Immunol 2014; 192 (8): 3569-81

252. Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin.

J Immunol 2013; 190 (10): 5207-15

PMC3864858 253. Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection.

J Immunol 2013; 190 (1): 296-306

PMC3294087 254. Hapivirins and diprovirins: novel theta-defensin analogs with potent activity against influenza A virus.

J Immunol 2012; 188 (6): 2759-68

PMC3392426 255. Transactivation of inducible nitric oxide synthase gene by Kruppel-like factor 6 regulates apoptosis during influenza A virus infection.

J Immunol 2012; 189 (2): 606-15

256. Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza.

J Immunol 2010; 184 (4): 2001-13

257. Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D.

J Immunol 2009; 182 (12): 7878-87

258. Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK.

J Immunol 2009; 182 (2): 1088-98

PMC4041086 259. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection.

J Immunol 2009; 182 (3): 1296-304

260. Agonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infection.

J Immunol 2008; 180 (10): 6903-10

261. Pattern recognition molecule mindin promotes intranasal clearance of influenza viruses.

J Immunol 2008; 180 (9): 6255-61

262. Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus.

J Immunol 2008; 181 (11): 7936-43

263. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules.

J Immunol 2006; 177 (3): 1817-24

264. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice.

J Immunol 2003; 171 (3): 1133-9

265. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages.

J Immunol 2002; 169 (10): 5673-8

266. Macrophages present pinocytosed exogenous antigen via MHC class I whereas antigen ingested by receptor-mediated endocytosis is presented via MHC class II.

J Immunol 2000; 165 (4): 1984-91

267. Type I IFN modulates innate and specific antiviral immunity.

J Immunol 2000; 164 (8): 4220-8

PMC5144727 268. Human Alveolar Macrophages May Not Be Susceptible to Direct Infection by a Human Influenza Virus.

J Infect Dis 2016; 214 (11): 1658-1665

PMC3935471 269. Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production.

J Infect Dis 2014; 209 (6): 865-75

PMC4038140 270. Massive mobilization of dendritic cells during influenza A virus subtype H5N1 infection of nonhuman primates.

J Infect Dis 2014; 209 (12): 2012-6

PMC3611767 271. Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1.

J Infect Dis 2013; 207 (2): 262-71

PMC3491741 272. H5N1 virus causes significant perturbations in host proteome very early in influenza virus-infected primary human monocyte-derived macrophages.

J Infect Dis 2012; 206 (5): 640-5

PMC3086437 273. Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection.

J Infect Dis 2011; 203 (1): 40-8

PMC4028720 274. Viral genetic determinants of H5N1 influenza viruses that contribute to cytokine dysregulation.

J Infect Dis 2009; 200 (7): 1104-1112

PMC6741508 275. Bacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity.

J Innate Immun 2014; 6 (2): 129-39

PMC4507134 276. Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection.

J Interferon Cytokine Res 2015; 35 (7): 554-62

PMC5597516 277. The theta-defensin retrocyclin 101 inhibits TLR4- and TLR2-dependent signaling and protects mice against influenza infection.

J Leukoc Biol 2017; 102 (4): 1103-1113

PMC4138204 278. Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection.

J Leukoc Biol 2014; 96 (3): 447-52

PMC6608022 279. Recombinant human mannose-binding lectin dampens human alveolar macrophage inflammatory responses to influenza A virus in vitro.

J Leukoc Biol 2014; 95 (5): 715-722

PMC2709305 280. Fish oil-fed mice have impaired resistance to influenza infection.

J Nutr 2009; 139 (8): 1588-94

PMC4885512 281. Tiotropium Attenuates Virus-Induced Pulmonary Inflammation in Cigarette Smoke-Exposed Mice.

J Pharmacol Exp Ther 2016; 357 (3): 606-18

PMC3412919 282. Proteome alterations in primary human alveolar macrophages in response to influenza A virus infection.

J Proteome Res 2012; 11 (8): 4091-101

283. Comprehensive characterisation of transcriptional activity during influenza A virus infection reveals biases in cap-snatching of host RNA sequences.

J Virol 2020; ä (ä): ä

284. IRF5 promotes influenza-induced inflammatory responses in human iPSC-derived myeloid cells and murine models.

J Virol 2020; ä (ä): ä

PMC6401432 285. Unique Transcriptional Architecture in Airway Epithelial Cells and Macrophages Shapes Distinct Responses following Influenza Virus Infection Ex Vivo.

J Virol 2019; 93 (6): ä

PMC6321928 286. Absence of beta6 Integrin Reduces Influenza Disease Severity in Highly Susceptible Obese Mice.

J Virol 2019; 93 (2): ä

PMC6321931 287. The NS1 Protein of Influenza A Virus Participates in Necroptosis by Interacting with MLKL and Increasing Its Oligomerization and Membrane Translocation.

J Virol 2019; 93 (2): ä

PMC5874408 288. NS1 Protein of 2009 Pandemic Influenza A Virus Inhibits Porcine NLRP3 Inflammasome-Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination.

J Virol 2018; 92 (8): ä

PMC5487567 289. Rubicon Modulates Antiviral Type I Interferon (IFN) Signaling by Targeting IFN Regulatory Factor 3 Dimerization.

J Virol 2017; 91 (14): ä

PMC4810543 290. The RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1beta Secretion.

J Virol 2016; 90 (8): 4105-4114

PMC4442436 291. Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction.

J Virol 2015; 89 (11): 6067-79

PMC4338877 292. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.

J Virol 2015; 89 (4): 2013-23

PMC4665238 293. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

J Virol 2015; 89 (24): 12319-29

PMC4645340 294. Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza Viruses.

J Virol 2015; 89 (23): 11935-44

PMC4645339 295. RIG-I Signaling Is Essential for Influenza B Virus-Induced Rapid Interferon Gene Expression.

J Virol 2015; 89 (23): 12014-25

PMC3993800 296. 17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.

J Virol 2014; 88 (9): 4711-20

PMC4097772 297. Importin-alpha7 is required for enhanced influenza A virus replication in the alveolar epithelium and severe lung damage in mice.

J Virol 2014; 88 (14): 8166-79

PMC3911739 298. Comparative virus replication and host innate responses in human cells infected with three prevalent clades (2.3.4, 2.3.2, and 7) of highly pathogenic avian influenza H5N1 viruses.

J Virol 2014; 88 (1): 725-9

PMC3911607 299. The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus.

J Virol 2014; 88 (3): 1659-72

PMC3676098 300. Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1.

J Virol 2013; 87 (12): 6925-30

PMC3554171 301. The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages.

J Virol 2013; 87 (3): 1411-9

PMC3416346 302. Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation.

J Virol 2012; 86 (13): 7192-206

PMC3196408 303. Type 1 responses of human Vgamma9Vdelta2 T cells to influenza A viruses.

J Virol 2011; 85 (19): 10109-16

PMC3194964 304. Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

J Virol 2011; 85 (21): 11208-19

PMC2812319 305. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.

J Virol 2010; 84 (3): 1414-22

PMC2849513 306. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry.

J Virol 2010; 84 (8): 3730-7

PMC2708648 307. Association of increased pathogenicity of Asian H5N1 highly pathogenic avian influenza viruses in chickens with highly efficient viral replication accompanied by early destruction of innate immune responses.

J Virol 2009; 83 (15): 7475-86

PMC1866007 308. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.

J Virol 2007; 81 (6): 2736-44

PMC1488970 309. Influenza virus evades innate and adaptive immunity via the NS1 protein.

J Virol 2006; 80 (13): 6295-304

PMC506954 310. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus.

J Virol 2004; 78 (17): 9499-511

PMC114307 311. Human lymphocyte apoptosis after exposure to influenza A virus.

J Virol 2001; 75 (13): 5921-9

312. Interferon production in rat type II pneumocytes and alveolar macrophages.

Exp Lung Res 1989; 15 (3): 429-45

313. Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages.

Free Radic Res 2014; 48 (8): 940-7

314. CD14 is required for influenza A virus-induced cytokine and chemokine production.

Immunobiology 2004; 209 (1-2): 3-10

315. Defense against influenza A virus infection: essential role of the chemokine system.

Immunobiology 2001; 204 (5): 603-13

316. Role of macrophage cytokines in influenza A virus infections.

Immunobiology 1993; 189 (3-4): 340-55

317. The potentiating effect of LPS on tumor necrosis factor-alpha production by influenza A virus-infected macrophages.

Immunobiology 1993; 187 (3-5): 357-71